| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |